CTL induction using synthetic peptides delivered in emulsions - critical role of the formulation procedure

Vaccine

Volumn 15, Issue 16, 1997, Pages 1773-1778

  Singh, Manmohan ^a,b   Hioe, Catarina ^a,c   Qiu, Howard ^a,d   Li, Xuan Mao ^a   Wang, Chang Yi ^a   Koff, Wayne ^a   Zamb, Timothy ^a,d   Nixon, Douglas F ^a,e  

^a United Biomedical Inc   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

^c NEW YORK UNIVERSITY   (United States)

^d PFIZER INC   (United States)

^e AARON DIAMOND AIDS RESEARCH CENTER   (United States)

Author keywords

CTL; Emulsion; Peptide

Indexed keywords

SOYBEAN OIL; SYNTHETIC PEPTIDE; VACCINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DRUG DELIVERY SYSTEM; EMULSION; FEMALE; IMMUNIZATION; MEASUREMENT; NONHUMAN; PRIORITY JOURNAL; TARGET CELL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS, PROTOZOAN; CHEMISTRY, PHARMACEUTICAL; CHEMISTRY, PHYSICAL; DRUG DELIVERY SYSTEMS; EMULSIONS; EPITOPES; FEMALE; HIV ANTIGENS; MICE; MICE, INBRED BALB C; PEPTIDES; PLASMODIUM BERGHEI; SOYBEANS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0030769073     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)00109-6     Document Type: Article

References (19)

1. Le Moignic, and Pinoy, Application to man of vaccines consisting of emulsions in fatty substances (lipo vaccines). Comptes Rendus de la Societe Biologique 1916, 79, 352.
2. Freund, J., Casals, J. and Homer, E. P. Sensitization and antibody formation after injection of tubercle bacilli and paraffin oil. Proceedings of the Society for Experimental Biology and Medicine 1937, 37, 509.
3. Hilleman, M. R. Critical appraisal of emulsified oil adjuvants applied to viral vaccines. Progress in Medical Virology 1966, 8, 131.
4. Kimura, J., Nariuchi, H., Watanbe, T., Matuhasi, T., Okayasu, I. and Hatakeyama, S. Studies on the adjuvant effect of water-in-oil-in-water emulsion in sesame oil I. Enhanced and persistent antibody formation by antigen incorporation into the water-in-oil-in-water emulsion. Japanese Journal of Experimental Medicine 1978, 48, 149.
5. Brugh, M., Stone, H. D. and Lipton, H. W. Comparison of inactivated Newcastle disease viral vaccines containing different emulsion adjuvants. American Journal of Veterinary Research 1983, 44, 72.
6. Herbert, W. J. Multiple emulsions adjuvants. Symposia Series on Immunobiology 1967, 6, 89.
7. Freestone, D. S., Hamilton, S., Schild, G. C., Buckland, R., Chinn, S. and Tyrell, D. A. J. Antibody responses and resistance to challenge in volunteers vaccinated with live attenuated detergent split and oil adjuvant A2/Hong Kong/68 (H3N2) influenza vaccines. Journal of Hygiene 1972, 70, 531.
8. Taylor, P. J., Miller, C. L., Pollock, T. M., Perkins, F. T. and Westwood, M. A. Antibody response and reactions to aqueous influenza vaccine, simple emulsion vaccine and multiple emulsion vaccine. Journal of Hygiene 1969, 67, 485.
9. Romero, P., Maryanski, J. L., Cordey, A.-S., Corradin, G., Nussenzweig, R. S. and Zavala, F. Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria. Nature 1989, 341, 323-326.
10. Takahashi, H., Cohen, J., Hosmalin, A., Cease, K. B., Houghten, R., Cornette, J. L., DeLisi, C., Moss, B., Germain, R. N. and Berzofsky, J. A. An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes. Proceedings of the National Academy of Science of the United States of America 1988, 85, (9), 3105-3109.
11. Borges, E., WiesmÅller, K.-H., Jung, G. and Walden, P. Efficacy of synthetic vaccines in the induction of cytotoxic T lymphocytes. Comparison of the costimulating support provided by helper T cells and lipoamino acid. Journal of Immunology Methods 1994, 173, 253-263.
12. Hioe, C. E., Qiu, H., Chen, P., Bian, Z., Li, M.-L., Li, J., Singh, M., Kuebler, P., McGee, J. P., O'Hagan, D. T., Zamb, T., Koff, W., Allsopp, C., Wang, C. Y. and Nixon, D. F. Comparison of adjuvant formulations for CTL induction using synthetic peptides. Vaccine 1996, 14, (5), 412-418.
13. Martin, A., Interfacial phenomena. In Physical Pharmacy, 4th edn, eds A. Martin, P. Bustomante and A.M.C. Chun. Lea & Febiger, London, 1993, pp. 387-388.
14. Martin, A. N., Journal of Pharmaceutical Sciences 1961, 50.
15. Nixon, D. F., McGee, J. P., Chen, P., Kuebler, P. J., Hioe, C., Richardson, J., Singh, M., Zamb, T., Koff, W., Wang, C. Y. and O'Hagan, D. T. Synthetic peptides entrapped in microparticles can elicit high levels of CTL activity. Vaccine 1996, 14, 1523-1530.
16. Jean-Paul, M. V., Julia, R. C. and Van Nest, G. A. Systemic cytokine profiles in BALB/c mice immunized with trivalent influenza vaccine containing MF59 oil emulsion and other advanced adjuvants. Journal of Immunology 1994, 7, 4029-4039.
17. Koup, R. A., Pikora, C. A., Luzuriaga, K., Brettler, D. B., Day, E. S., Mazzara, G. P. and Sullivan, J. L. Temporal association of cellular immune responses with the initial control of viremia in primary HIV-1 syndrome. Journal of Virology 1994, 68, 4650-4655.
18. Borrow, P., Lewicki, H., Hahn, B. H., Shaw, G. M. and Oldstone, M. B. Virus specific CD8+ cytotoxic T lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. Journal of Virology 1994, 68, 6103-6110.
19. Ada, G. L. and McElrath, M. J. HIV type 1 vaccine-induced cytotoxic T cell responses: potential role in vaccine efficacy. AIDS Research and Human Retroviruses 1997, 205-210.